Skip to main content

Table 2 Embryo outcomes in COVID-19 and non-COVID-19 group

From: Effect of SARS-CoV-2 infection on human embryonic development and clinical outcomes: a retrospective cohort study

Parameter

COVID−19

non-COVID−19

P

Fertilization type, n (%)

  

0.230

 IVF

114(72.6)

295(77.4)

 

 ICSI

43(27.4)

86(22.6)

 

Rescue ICSI

1(2.3)

3(3.4)

 

Stimulation days(Mean ± SD)

10.350 ± 2.422

9.900 ± 2.617

0.451

Total dose of Gn, IU(Mean ± SD)

2401.194 ± 903.986

2325.893 ± 900.259

0.379

No. Of Retrieved oocytes

10.191 ± 5.730

9.580 ± 6.752

0.320

Normal fertilization rate, (%)

62.2(933/1509)

64.7(2217/3428)

0.113

Available embryos rate (%)*

86.7(814/939)*

83.8(1858/2217)

0.000

Good-quality embryos rate(%)

56.2(528/939)

59.5(1319/2217)

0.132

Blastocyst formation rate(%)

60.9(418/686)

61.7(977/1584)

0.293

  1. Note *P < .05